October 26, 2025
avatar-torie-bosch
First Opinion editor

On the “First Opinion Podcast” this week, I spoke with Jake Eberts and Jill Fisher about how to determine fair, ethical pay for healthy medical research volunteers. Eberts knows of which he speaks: He contracted dysentery in a vaccine trial for which he was paid $7,300. While in the U.S. the disease is largely associated with “The Oregon Trail” and past centuries, it remains deadly for many around the world. We talked about institutional review boards, who is really most likely to volunteer for these kinds of studies (it’s not, in fact, broke college students!), and much more.

Recommendation of the week: In The Cut, E.J. Dickson writes about the concept of “Deeply Feeling Kids” and whether it, and the community around it, might delay parents from seeking a diagnosis for a neurodivergent child.



Adobe

Tear down the wall between neurology and psychiatry

Medicine needs to embrace the brain’s messy, interconnected reality and break down the barrier between psychiatry and neurology.

By Shaheen E. Lakhan


Climate and health strategies must address the biodiversity crisis

Without integrating biodiversity into climate and health strategies, efforts to stabilize climate and protect public health will fall short.

By Neil Vora and Chris Walzer


Trump’s $150-per-month GLP-1 plan won’t reach people like me

I use GLP-1s off-label to help manage life in long-term recovery from addiction — but their cost has driven me to risky things.

By Nick Dothée


Adobe

STAT+ | TrumpRx and a most favored nation policy won’t lower prices for patients

A truly game-changing policy would align U.S. generic drug entry with other countries’ timelines.

By Tahir Amin


How to tease out what’s causation and what’s just correlation

The acetaminophen-autism debate highlights the challenge of studying cause and effect — and some solutions.

By Cordelia Kwon and Elizabeth Stuart


Corporate support cannot make up for threats to the NIH budget

Many are turning to private industry to fund research whose NIH support is at risk. But privatization of medical research has its own problems.

By Jerry Avorn


Molly Ferguson for STAT

Is new insurance company downcoding long overdue or a travesty? STAT readers weigh in

STAT readers respond to recent controversial essays on insurance downcoding, gain of function research, and more.

By Torie Bosch


Would you contract dysentery for $7,300?

On the “First Opinion Podcast,” Jill Fisher and Jake Eberts discuss their work on compensation for healthy medical research volunteers.

By Torie Bosch


The U.S. experiment with profit-driven health care has failed

The U.S. experiment with profit-driven health care has failed. It’s time to change everything

By Steffie Woolhandler, David U. Himmelstein, Adam W. Gaffney, and Danny McCormick


SARS-CoV-2.
NIAID

The origins of Covid and public health’s uncertainty problem

We’re teaching our public health graduate students about the Covid origin debate to equip them for the future

By Michaela Kerrissey and Richard J. Tofel


How to keep commercial surrogacy from getting banned

An alliance among some religious groups, members of the Make America Healthy Again movement, and feminists is gaining ground

By Arthur L. Caplan


CMS says it’s cutting fraud. Patients like me may pay the price with our lives

CMS’s new policy means limited product availability, fewer suppliers, delivery delays, and a higher risk of medical emergencies.

By Ali Ingersoll


More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

Enjoying First Opinion? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2025, All Rights Reserved.